Michael Huber is President and Chief Executive Officer of Mersana Therapeutics, Inc. (MRSN). The company reported total compensation of $1,613,754 for fiscal year 2024.
| Salary | $632,500 |
|---|---|
| Bonus | $0 |
| Stock awards | $133,635 |
| Option awards | $518,044 |
| Non-equity incentive plan | $322,575 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $7,000 |
| Total | $1,613,754 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Mersana Therapeutics, Inc. filed April 29, 2025, accession 0001104659-25-040448.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2024 | President and Chief Executive Officer | $632,500 | $0 | $133,635 | $518,044 | $322,575 | $0 | $7,000 | $1,613,754 |
| FY2023 | President and Chief Executive Officer | $194,311 | $0 | $880,440 | $1,133,300 | $110,466 | $0 | $282,733 | $2,601,249 |
Totals as disclosed in each year's own compensation disclosure for Mersana Therapeutics, Inc..
| Peer-group chief executive median | $2,812,721 |
|---|---|
| Difference from that median | $-1,198,967 |
| Percentile within the disclosed peer group | 10th |
| Peers with a disclosed figure | 10 |
Medians and percentiles are computed across the peer group Mersana Therapeutics, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2024 total |
|---|---|---|
| Michael Huber this page | President and Chief Executive Officer | $1,613,754 |
| Brian DeSchuytner | Senior Vice President, Chief Operating Officer and Chief Financial Officer | $1,543,586 |
| Mohan Bala | Senior Vice President, Chief Development Officer | $1,502,936 |
| Timothy Lowinger | Senior Vice President, Chief Science and Technology Officer | $1,400,535 |
| Alejandra Carvajal | Senior Vice President, Chief Legal Officer | $1,359,885 |
The company's named executive officers for fiscal year 2024, and what it reported for each. See the full Mersana Therapeutics, Inc. compensation brief.
Michael Huber's compensation sits inside Mersana Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.